Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown

被引:0
作者
Xiaodong Qin
Yuping Du
Xing Chen
Wuyan Li
Jinghong Zhang
Jinbo Yang
机构
[1] Lanzhou University,School of Life Science
[2] Muskingum University,Department of Engineering Science
[3] Huaqiao University,School of Biomedical Science and Institutes of Molecule Medicine
[4] Lerner Research Institute,Department of Cancer Biology
[5] The Cleveland Clinic Foundation,undefined
来源
Cell & Bioscience | / 4卷
关键词
H1299 Cell; Pyruvate Kinase; PI3K Inhibitor; Knockdown Efficiency; Metabolic Reprogram;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 67 条
[1]  
Fresno Vara JA(2004)PI3K/Akt signalling pathway and cancer Cancer Treat Rev 30 193-204
[2]  
Casado E(2007)Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 3291-3310
[3]  
de Castro J(2008)The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 230-233
[4]  
Cejas P(2013)Site-specific activation of AKT protects cells from death induced by glucose deprivation Oncogene 33 745-755
[5]  
Belda-Iniesta C(2013)PKM2, A central point of regulation in cancer metabolism Int J Cell Biol 2013 242513-5561
[6]  
Gonzalez-Baron M(2012)Pyruvate kinase m2: multiple faces for conferring benefits on cancer cells Clin Cancer Res 18 5554-17
[7]  
Roberts PJ(2012)Metabolic regulation of epigenetics Cell Metab 16 9-4134
[8]  
Der CJ(2011)Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth Proc Natl Acad Sci U S A 108 4129-6253
[9]  
Christofk HR(2013)Erlotinib resistance in lung cancer cells mediated by integrin beta1/Src/Akt-driven bypass signaling Cancer Res 73 6243-undefined
[10]  
Vander Heiden MG(undefined)undefined undefined undefined undefined-undefined